Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study.
Saved in:
| Title: | Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study. |
|---|---|
| Authors: | Dickey A; Division of Pulmonary and Critical Care Medicine, Department of Medicine Massachusetts General Hospital Boston Massachusetts USA., Wheeden K; American Porphyria Foundation Bethesda Maryland USA., Lyon D; American Porphyria Foundation Bethesda Maryland USA., Burrell S; Global Porphyria Advocacy Coalition Durham City UK., Hegarty S; Global Porphyria Advocacy Coalition Durham City UK., Falchetto R; Swiss Society for Porphyria Zürich Switzerland., Williams ER; American Porphyria Foundation Bethesda Maryland USA., Barman-Aksözen J; Swiss Society for Porphyria Zürich Switzerland.; Institute of Laboratory Medicine, Department of Medical Institutes Stadtspital Zürich, Triemli Zürich Switzerland., DeCongelio M; Cerner Enviza (formerly Kantar Health) New York New York USA., Bulkley A; Cerner Enviza (formerly Kantar Health) New York New York USA., Matos JE; Cerner Enviza (formerly Kantar Health) Kansas City Missouri USA., Mnif T; Cerner Enviza (formerly Kantar Health) Paris France., Mora J; Alnylam Pharmaceuticals Cambridge Massachusetts USA., Ko JJ; Alnylam Pharmaceuticals Cambridge Massachusetts USA., Meninger S; Alnylam Pharmaceuticals Cambridge Massachusetts USA., Lombardelli S; Alnylam Pharmaceuticals Maidenhead UK., Nance D; Banner Health Gilbert Arizona USA. |
| Source: | JIMD reports [JIMD Rep] 2022 Oct 18; Vol. 64 (1), pp. 104-113. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101568557 Publication Model: eCollection Cited Medium: Print ISSN: 2192-8304 (Print) Linking ISSN: 21928304 NLM ISO Abbreviation: JIMD Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36636593 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dickey+A%22">Dickey A</searchLink>; Division of Pulmonary and Critical Care Medicine, Department of Medicine Massachusetts General Hospital Boston Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Wheeden+K%22">Wheeden K</searchLink>; American Porphyria Foundation Bethesda Maryland USA.<br /><searchLink fieldCode="AU" term="%22Lyon+D%22">Lyon D</searchLink>; American Porphyria Foundation Bethesda Maryland USA.<br /><searchLink fieldCode="AU" term="%22Burrell+S%22">Burrell S</searchLink>; Global Porphyria Advocacy Coalition Durham City UK.<br /><searchLink fieldCode="AU" term="%22Hegarty+S%22">Hegarty S</searchLink>; Global Porphyria Advocacy Coalition Durham City UK.<br /><searchLink fieldCode="AU" term="%22Falchetto+R%22">Falchetto R</searchLink>; Swiss Society for Porphyria Zürich Switzerland.<br /><searchLink fieldCode="AU" term="%22Williams+ER%22">Williams ER</searchLink>; American Porphyria Foundation Bethesda Maryland USA.<br /><searchLink fieldCode="AU" term="%22Barman-Aksözen+J%22">Barman-Aksözen J</searchLink>; Swiss Society for Porphyria Zürich Switzerland.; Institute of Laboratory Medicine, Department of Medical Institutes Stadtspital Zürich, Triemli Zürich Switzerland.<br /><searchLink fieldCode="AU" term="%22DeCongelio+M%22">DeCongelio M</searchLink>; Cerner Enviza (formerly Kantar Health) New York New York USA.<br /><searchLink fieldCode="AU" term="%22Bulkley+A%22">Bulkley A</searchLink>; Cerner Enviza (formerly Kantar Health) New York New York USA.<br /><searchLink fieldCode="AU" term="%22Matos+JE%22">Matos JE</searchLink>; Cerner Enviza (formerly Kantar Health) Kansas City Missouri USA.<br /><searchLink fieldCode="AU" term="%22Mnif+T%22">Mnif T</searchLink>; Cerner Enviza (formerly Kantar Health) Paris France.<br /><searchLink fieldCode="AU" term="%22Mora+J%22">Mora J</searchLink>; Alnylam Pharmaceuticals Cambridge Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Ko+JJ%22">Ko JJ</searchLink>; Alnylam Pharmaceuticals Cambridge Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Meninger+S%22">Meninger S</searchLink>; Alnylam Pharmaceuticals Cambridge Massachusetts USA.<br /><searchLink fieldCode="AU" term="%22Lombardelli+S%22">Lombardelli S</searchLink>; Alnylam Pharmaceuticals Maidenhead UK.<br /><searchLink fieldCode="AU" term="%22Nance+D%22">Nance D</searchLink>; Banner Health Gilbert Arizona USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568557%22">JIMD reports</searchLink> [JIMD Rep] 2022 Oct 18; Vol. 64 (1), pp. 104-113. <i>Date of Electronic Publication: </i>2022 Oct 18 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568557 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2192-8304 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221928304%22">21928304 </searchLink><i>NLM ISO Abbreviation: </i>JIMD Rep <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36636593 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/jmd2.12343 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104 Titles: – TitleFull: Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dickey A – PersonEntity: Name: NameFull: Wheeden K – PersonEntity: Name: NameFull: Lyon D – PersonEntity: Name: NameFull: Burrell S – PersonEntity: Name: NameFull: Hegarty S – PersonEntity: Name: NameFull: Falchetto R – PersonEntity: Name: NameFull: Williams ER – PersonEntity: Name: NameFull: Barman-Aksözen J – PersonEntity: Name: NameFull: DeCongelio M – PersonEntity: Name: NameFull: Bulkley A – PersonEntity: Name: NameFull: Matos JE – PersonEntity: Name: NameFull: Mnif T – PersonEntity: Name: NameFull: Mora J – PersonEntity: Name: NameFull: Ko JJ – PersonEntity: Name: NameFull: Meninger S – PersonEntity: Name: NameFull: Lombardelli S – PersonEntity: Name: NameFull: Nance D IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 10 Text: 2022 Oct 18 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2192-8304 Numbering: – Type: volume Value: 64 – Type: issue Value: 1 Titles: – TitleFull: JIMD reports Type: main |
| ResultId | 1 |